298 related articles for article (PubMed ID: 29503620)
1. Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.
Lv W; Booz GW; Fan F; Wang Y; Roman RJ
Front Physiol; 2018; 9():105. PubMed ID: 29503620
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targets for treating fibrotic kidney diseases.
Lee SY; Kim SI; Choi ME
Transl Res; 2015 Apr; 165(4):512-30. PubMed ID: 25176603
[TBL] [Abstract][Full Text] [Related]
3. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
4. The role of cGMP and its signaling pathways in kidney disease.
Shen K; Johnson DW; Gobe GC
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F671-F681. PubMed ID: 27413196
[TBL] [Abstract][Full Text] [Related]
5. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.
Zhang JJ; Bledsoe G; Kato K; Chao L; Chao J
Kidney Int; 2004 Aug; 66(2):722-32. PubMed ID: 15253727
[TBL] [Abstract][Full Text] [Related]
6. Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway.
Wang W; Ma BL; Xu CG; Zhou XJ
Phytomedicine; 2020 Apr; 69():153185. PubMed ID: 32120244
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β.
Yeh YH; Kuo CT; Chang GJ; Qi XY; Nattel S; Chen WJ
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):790-8. PubMed ID: 23884197
[TBL] [Abstract][Full Text] [Related]
8. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway.
Soetikno V; Sari FR; Lakshmanan AP; Arumugam S; Harima M; Suzuki K; Kawachi H; Watanabe K
Mol Nutr Food Res; 2013 Sep; 57(9):1649-59. PubMed ID: 23174956
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of p53 regulation of oxidative stress in skeletal muscle.
Beyfuss K; Hood DA
Redox Rep; 2018 Dec; 23(1):100-117. PubMed ID: 29298131
[TBL] [Abstract][Full Text] [Related]
10. Redox signaling in aging kidney and opportunity for therapeutic intervention through natural products.
Chen YY; Yu XY; Chen L; Vaziri ND; Ma SC; Zhao YY
Free Radic Biol Med; 2019 Sep; 141():141-149. PubMed ID: 31199964
[TBL] [Abstract][Full Text] [Related]
11. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and Modulation of Oxidative/Nitrative Stress in Type 4 Cardio-Renal Syndrome and Renal Sarcopenia.
Sárközy M; Kovács ZZA; Kovács MG; Gáspár R; Szűcs G; Dux L
Front Physiol; 2018; 9():1648. PubMed ID: 30534079
[TBL] [Abstract][Full Text] [Related]
13. [The improvement effects of Yiqi Huashi Tongluo Formula on oxidative stress and renal fibrosis of experimental CRF rats].
Zhu XT; Chen ZQ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jan; 36(1):67-72. PubMed ID: 32476375
[TBL] [Abstract][Full Text] [Related]
14. Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists.
Deng YL; Xiong XZ; Cheng NS
Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):467-78. PubMed ID: 23060391
[TBL] [Abstract][Full Text] [Related]
15. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q
J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
Kim J; Yoon SP; Toews ML; Imig JD; Hwang SH; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F131-9. PubMed ID: 25377915
[TBL] [Abstract][Full Text] [Related]
17. Fimasartan, a Novel Angiotensin-Receptor Blocker, Protects against Renal Inflammation and Fibrosis in Mice with Unilateral Ureteral Obstruction: the Possible Role of Nrf2.
Kim S; Kim SJ; Yoon HE; Chung S; Choi BS; Park CW; Shin SJ
Int J Med Sci; 2015; 12(11):891-904. PubMed ID: 26640409
[TBL] [Abstract][Full Text] [Related]
18. Intermedin inhibits unilateral ureteral obstruction-induced oxidative stress via NADPH oxidase Nox4 and cAMP-dependent mechanisms.
Qiao X; Wang L; Wang Y; Su X; Qi Y; Fan Y; Peng Z
Ren Fail; 2017 Nov; 39(1):652-659. PubMed ID: 28805491
[TBL] [Abstract][Full Text] [Related]
19. Effects of estradiol on renal cyclic guanosine monophosphate and oxidative stress in spontaneously hypertensive rats.
Sullivan JC; Pardieck JL; Brinson K; Kang KT
Gend Med; 2009 Sep; 6(3):498-510. PubMed ID: 19850246
[TBL] [Abstract][Full Text] [Related]
20. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress.
Shen B; Hagiwara M; Yao YY; Chao L; Chao J
Hypertension; 2008 May; 51(5):1358-65. PubMed ID: 18391098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
